| Subject: | CDC Issues New Recommendations for Meningococcal Conjugate Vaccine due to Supply Limitations |
| Category: | Centers for Disease Control and Prevention (CDC)
|
| Published: | Wed, 31 May 2006 - 10:00 am |
| Sanofi Pasteur, the manufacture of MCV4, (a tetravalent meningococcal polysaccharide-protein conjugate vaccine), anticipates that MCV4 demand will outpace supply at least through summer 2006. Therefore the CDC is making modifications to its recommendations for meningococcal conjugate vaccination.
Due to the potential shortages, the CDC, in consultation with ACIP, the American Academy of Pediatrics, American Academy of Family Physicians, American College Health Association, and Society for... The full article is available to StayAlert subscribers. Click here for a free trial subscription. |
|
RESOURCES:
External Links:
Related MCN Products:
|
|
With over 20 years experience in regulatory compliance, MCN Healthcare brings you the most comprehensive regulatory compliance tool available. StayAlert! is the only comprehensive e-mail notification service available that not only notifies you of the changes in major federal regulations, but also provides the policies, procedures, tools and best practices to help you meet the changing regulation. StayAlert! actively monitors TJC (JCAHO), CDC, CMS, DHHS, FDA, OSHA, OIG and many others so you don't have to. Currently StayAlert! is the leader in the comprehensive compliance information marketplace. Why? Because StayAlert! provides healthcare professionals with more than information. StayAlert! provides a service, in many cases "doing the work" for you, and assisting regulatory compliance officers to effectively and efficiently meet changing standards. |
|
